Selected article for: "antiviral target and life cycle"
Author: Lou, Zhiyong; Sun, Yuna; Rao, Zihe
Title: Current progress in antiviral strategies
  • Cord-id: 2vy28i4m
  • Document date: 2014_1_14
    • ID: 2vy28i4m
    Snippet: The prevalence of chronic viral infectious diseases, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), and influenza virus; the emergence and re-emergence of new viral infections, such as picornaviruses and coronaviruses; and, particularly, resistance to currently used antiviral drugs have led to increased demand for new antiviral strategies and reagents. Increased understanding of the molecular mechanisms of viral infection has provided great potential for the discovery of ne
    Document: The prevalence of chronic viral infectious diseases, such as human immunodeficiency virus (HIV), hepatitis C virus (HCV), and influenza virus; the emergence and re-emergence of new viral infections, such as picornaviruses and coronaviruses; and, particularly, resistance to currently used antiviral drugs have led to increased demand for new antiviral strategies and reagents. Increased understanding of the molecular mechanisms of viral infection has provided great potential for the discovery of new antiviral agents that target viral proteins or host factors. Virus-targeting antivirals can function directly or indirectly to inhibit the biological functions of viral proteins, mostly enzymatic activities, or to block viral replication machinery. Host-targeting antivirals target the host proteins that are involved in the viral life cycle, regulating the function of the immune system or other cellular processes in host cells. Here we review key targets and considerations for the development of both antiviral strategies.

    Search related documents:
    Co phrase search for related documents
    • active compound and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • active inhibitor and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • active site and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and additional function: 1
    • active site and additional target: 1, 2, 3, 4
    • active site and adenosine triphosphate: 1, 2, 3, 4
    • active site and loop region: 1, 2, 3, 4, 5, 6
    • active site and low affinity site: 1
    • acute sars cov respiratory syndrome coronavirus and additional function: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and additional target: 1, 2, 3
    • acute sars cov respiratory syndrome coronavirus and adenosine triphosphate: 1, 2, 3, 4, 5, 6
    • acute sars cov respiratory syndrome coronavirus and liver cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute sars cov respiratory syndrome coronavirus and loop region: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11